| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $4.5M | +2.3% |
| Cost of Revenue | $687K | +12.5% |
| Gross Profit | $3.8M | +0.7% |
| R&D Expense | $1.8M | +16.5% |
| SG&A Expense | $989K | +41.6% |
| Operating Income | -$663K | -1194.9% |
| Pre-tax Income | -$638K | -670.8% |
| Income Tax | $0 | — |
| Net Income | -$638K |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -24.5% |
| Accounts Receivable | $863K | +26.8% |
| Current Assets | $2.2M | -7.9% |
| Total Assets | $3.0M | -19.6% |
| Current Liabilities | $544K | +4.1% |
| Total Liabilities | $544K | +4.1% |
| Stockholders' Equity | $2.4M | -23.5% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $65K | -84.8% |
| Capital Expenditures | $29K | +257.0% |
| Investing Cash Flow | -$335K | +30.8% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | $36K | -91.4% |
| -670.8% |
| EPS (Basic) | -$0.07 | -800.0% |
| EPS (Diluted) | -$0.07 | -800.0% |